American Thoracic Society Launches Major Initiative to Close Massive Sleep Apnea Diagnostic Gap
DNI SUMMARY — KEY POINTS
- The American Thoracic Society has officially launched a new quality improvement initiative specifically designed to address significant gaps in the screening and diagnosis of obstructive sleep apnea within primary care settings.
- Four major healthcare systems including the West Virginia University and the VA Pittsburgh Healthcare System are collaborating with the organization to streamline testing processes and improve patient identification.
- Current data from the National Institutes of Health indicates that while 83 million Americans suffer from obstructive sleep apnea, nearly 90 percent of these individuals currently remain undiagnosed.
- ATS president Michelle Ng Gong highlighted that the primary goal of the project is to dismantle systemic barriers that prevent patients from accessing necessary sleep medicine specialists and diagnostic services.
- The project has officially entered its implementation phase where researchers will refine and evaluate specific medical interventions across participating partner institutions to ensure long-term clinical efficacy and accessibility.
The American Thoracic Society has taken a significant step toward addressing the silent epidemic of sleep-related breathing disorders by launching a targeted quality improvement project. This initiative aims to bridge the critical divide between primary care settings and specialized sleep medicine by streamlining diagnostic protocols for obstructive sleep apnea. By focusing on early detection at the point of primary contact, the organization intends to fundamentally transform how patients with suspected respiratory issues are identified and referred for further clinical evaluation across the United States.
Bridging The Diagnostic Gap
Bridging The Diagnostic Gap
Funding for this ambitious project is provided by Eli Lilly, enabling a robust collaboration between the medical society and several prominent healthcare systems. Participating institutions include the West Virginia University, the VA Pittsburgh Healthcare System, the San Francisco Health Network, and the Mount Sinai Health System. These organizations serve as the initial testing ground for implementing evidence-based screening tools designed to integrate seamlessly into daily practice workflows, potentially offering a scalable blueprint for other clinics nationwide to adopt for their patient populations.
An estimated 83 million Americans currently live with obstructive sleep apnea according to recent data from the National Institutes of Health.
Systemic Barriers To Care
The urgency of this intervention is underscored by staggering statistics released by the National Institutes of Health. Current estimates reveal that approximately 83 million Americans are living with obstructive sleep apnea, yet a vast majority of these individuals lack a formal clinical diagnosis. This diagnostic deficit often leaves millions vulnerable to secondary health complications such as cardiovascular disease, hypertension, and excessive daytime fatigue, which significantly degrade overall quality of life and place an immense burden on the broader public health infrastructure.
Systemic Barriers To Care
Optimizing Clinical Operational Workflows
Systemic hurdles currently prevent primary care physicians from effectively screening for sleep disorders during routine wellness visits. Patients often encounter fragmented referral pathways that discourage them from pursuing comprehensive sleep studies after initial symptom reporting. The new ATS initiative seeks to simplify these processes by empowering primary care providers with the diagnostic instruments and support needed to identify high-risk individuals early. This structural shift is expected to reduce wait times and ensure that resources are directed efficiently toward the patients who require urgent specialist intervention.
Approximately 80 to 90 percent of individuals suffering from obstructive sleep apnea remain undiagnosed in the current healthcare system.
Leadership at the professional society remains committed to the principle of health equity throughout this project. Michelle Ng Gong, serving as president, emphasized that addressing these barriers is essential to ensuring that no demographic is left behind due to inefficiencies in the existing clinical framework. By focusing on both general and site-specific operational challenges, the participating healthcare systems hope to establish a more inclusive and effective model for managing sleep disorders that can be sustained long after the pilot phase concludes.
Scaling Solutions For Future Healthcare
Optimizing Clinical Operational Workflows
Project organizers are currently moving into the evaluation phase to rigorously test and refine interventions within the four partner healthcare systems. This hands-on approach allows for real-time adjustments based on the unique operational needs of each medical environment. The data gathered during this period will be pivotal in shaping future policy recommendations and clinical guidelines, potentially setting a new gold standard for how chronic respiratory conditions are managed within the context of primary care medicine across various geographic regions.
Long-term success for this initiative relies on the sustained engagement of physicians and the modernization of electronic health records. As the systems move forward, the focus will shift toward measuring outcomes related to patient referral rates and the time elapsed from initial screening to receiving an official diagnosis. If the project demonstrates consistent improvements, the methodology could provide a robust framework for managing other complex conditions that are frequently overlooked in the busy, high-volume environment of contemporary primary care practices.
KEY TAKEAWAYS
The new quality improvement initiative is officially funded by Eli Lilly to help streamline testing processes within primary care settings.
Four major healthcare systems are currently collaborating with the American Thoracic Society to test and refine new diagnostic interventions for patients.

